Search Results - "ИНТЕРСТИЦИАЛЬНАЯ ПНЕВМОНИЯ"

Contributors: The study was carried out within the framework of the Comprehensive Scientific and Technical Program of the Full Innovation Cycle entitled “Development and implementation of technologies in the field of exploration and extraction of solid minerals, industrial safety, bioremediation, obtaining new products of deep processing from raw coal with a consistent reduction in the environmental burden and environmental impact on the life of the population” (approved by Order of the Russian Federation Government No. 1144-r dated May 11, 2022, the Agreement No. 075-15-2022-1202 dated September 30, 2022)., Исследование выполнено в рамках Комплексной научно-технической программы полного инновационного цикла «Разработка и внедрение комплекса технологий в области разведки и добычи твердых полезных ископаемых, обеспечения промышленной безопасности, биоремедиации, создания новых продуктов глубокой переработки из угольного сырья при последовательном снижении экологической нагрузки на окружающую среду и рисков для жизни населения» (утв. Распоряжением Правительства РФ от 11 мая 2022 г. № 1144-р, Соглашение № 075-15-2022-1202 от 30 сентября 2022 г.).

Source: Siberian Journal of Clinical and Experimental Medicine; Том 38, № 2 (2023); 64-71 ; Сибирский журнал клинической и экспериментальной медицины; Том 38, № 2 (2023); 64-71 ; 2713-265X ; 2713-2927

Subject Terms: фиброз легких, COVID-19, рost-COVID syndrome, interstitial pneumonia, organizing pneumonia, secondary organizing pneumonia, pulmonary fibrosis, постковидный синдром, интерстициальная пневмония, организующаяся пневмония, вторичная организующаяся пневмония

File Description: application/pdf

Relation: https://www.sibjcem.ru/jour/article/view/1788/814; Баздырев Е.Д. Коронавирусная инфекция – актуальная проблема XXI века. Комплексные проблемы сердечно-сосудистых заболеваний. 2020;9(2):6–16. DOI:10.17802/2306-1278-2020-9-2-6-16.; Wu X., Liu X., Zhou Y., Yu H., Li R., Zhan Q. et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir. Med. 2021;9(7):747–754. DOI:10.1016/S2213-2600(21)00174-0.; Raoufi M., Kahkooei S., Haseli S., Robatjazi F., Bahri J., Khalili N. Organizing pneumonia-like pattern in COVID-19. Advances in Respiratory Medicine. 2021;89(6):565–569. DOI:10.5603/ARM.a2021.0081.; Wang Y., Jin C., Wu C.C., Zhao H., Liang T., Liu Z. et al. Organizing pneumonia of COVID-19: Time-dependent evolution and outcome in CT findings. PLoS One. 2020;15(11):e0240347. DOI:10.1371/journal.pone.0240347.; Horii H., Kamada K., Nakakubo S., Yamashita Y., Nakamura J., Nasuhara Y. et al. Rapidly progressive organizing pneumonia associated with COVID-19. Respir. Med. Case Rep. 2020;31:101295. DOI:10.1016/j.rmcr.2020.101295.; Bradley B., Branley H.M., Egan J.J., Greaves M.S., Hansell D.M., Harrison N.K. et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63(S5):v1–58. DOI:10.1136/thx.2008.101691.; Kligerman S.J., Franks T.J., Galvin J.R. From the radiologic pathology archives: organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia. Radiographics. 2013;33(7):1951–1975. DOI:10.1148/rg.337130057.; Pathak V., Kuhn J.M., Durham C., Funkhouser W.K., Henke D.C. Macrolide use leads to clinical and radiological improvement in patients with cryptogenic organizing pneumonia. Ann. Am. Thorac. Soc. 2014;11(1):87–91. DOI:10.1513/AnnalsATS.201308-261CR.; Cai M., Bonella F., Dai H., Sarria R., Guzman J., Costabel U. Macrolides inhibit cytokine production by alveolar macrophages in bronchiolitis obliterans organizing pneumonia. Immunobiology. 2013;218(6):930–937. DOI:10.1016/j.imbio.2012.10.014.; Poletti V., Cazzato S., Minicuci N., Zompatori M., Burzi M., Schiattone M.L. The diagnostic value of bronchoalveolar lavage and transbronchial lung biopsy in cryptogenic organizing pneumonia. Eur. Respir. J. 1996;9(12):2513–2516. DOI:10.1183/09031936.96.09122513.; Lee W.L., Downey G.P. Neutrophil activation and acute lung injury. Curr. Opin. Crit. Care. 2001;7(1):1–7. DOI:10.1097/00075198-200102000-00001.; Ma Y., Zhang Y., Zhu L. Role of neutrophils in acute viral infection. Immun. Inflamm. Dis. 2021;9(4):1186–1196. DOI:10.1002/iid3.500.; Radzikowska E., Roży A., Jaguś P., Wiatr E., Gawryluk D., Chorostowska-Wynimko J. et al. Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment. Adv. Exp. Med. Biol. 2016;911:77–85. DOI:10.1007/5584_2016_223.; Baha A., Yıldırım F., Köktürk N., Galata Z., Akyürek N., Demirci N.Y. et al. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiological and laboratory findings, treatment, and prognosis in 56 cases. Turk Thorac. J. 2018;19(4):201–208. DOI:10.5152/TurkThoracJ.2018.18008.; Gudmundsson G., Sveinsson O., Isaksson H.J., Jonsson S., Frodadottir H., Aspelund T. Epidemiology of organising pneumonia in Iceland. Thorax. 2006;61(9):805–808. DOI:10.1136/thx.2006.059469.; Allen J.N., Wewers M.D. HIV-associated bronchiolitis obliterans organizing pneumonia. Chest. 1989;96(1):197–198. DOI:10.1378/chest.96.1.197.; Nuñez-Conde A., Marquez-Algaba E., Falcó V., Almirante B., Burgos J. Organizing pneumonia secondary to influenza infection: Two case reports and a literature review. Enferm. Infecc. Microbiol. Clin. (Engl. Ed.). 2020;38(3):123–126. (In Span.). DOI:10.1016/j.eimc.2019.04.006.; Messina M., Scichilone N., Guddo F., Bellia V. Rapidly progressive organising pneumonia associated with cytomegalovirus infection in a patient with psoriasis. Monaldi Arch. Chest Dis. 2007;67(3):165–168. DOI:10.4081/monaldi.2007.489.; Myall K.J., Mukherjee B., Castanheira A.M., Lam J.L., Benedetti G., Mak S.M. et al. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Ann. Am. Thorac. Soc. 2021;18(5):799–806. DOI:10.1513/AnnalsATS.202008-1002OC.; Drakopanagiotakis F., Paschalaki K., Abu-Hijleh M., Aswad B., Karagianidis N., Kastanakis E. et al. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis. Chest. 2011;139(4):893–900. DOI:10.1378/chest.10-0883.; Choi K.J., Yoo E.H., Kim K.C., Kim E.J. Comparison of clinical features and prognosis in patients with cryptogenic and secondary organizing pneumonia. BMC Pulm. Med. 2021;21(1):336. DOI:10.1186/s12890-021-01707-z.; Chandra D., Maini R., Hershberger D.M. Cryptogenic Organizing Pneumonia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.; Greenberg-Wolff I., Konen E., Ben Dov I., Simansky D., Perelman M., Rozenman J. Cryptogenic organizing pneumonia: variety of radiologic findings. Isr. Med. Assoc. J. 2005;7(9):568–570.; Demedts M., Costabel U. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur. Respir. J. 2002;19(5):794–796. DOI:10.1183/09031936.02.00492002.; Wong K.T., Antonio G.E., Hui D.S., Ho C., Chan P.N., Ng W.H. et al. Severe acute respiratory syndrome: thin-section computed tomography features, temporal changes, and clinicoradiologic correlation during the convalescent period. J. Comput. Assist. Tomogr. 2004;28(6):790–795. DOI:10.1097/00004728-200411000-00010.; Nishino M., Mathai S.K., Schoenfeld D., Digumarthy S.R., Kradin R.L. Clinicopathologic features associated with relapse in cryptogenic organizing pneumonia. Hum. Pathol. 2014;45(2):342–351. DOI:10.1016/j.humpath.2013.09.010.; Onishi Y., Kawamura T., Higashino T., Mimura R., Tsukamoto H., Sasaki S. Clinical features of acute fibrinous and organizing pneumonia: An early histologic pattern of various acute inflammatory lung diseases. PLoS One. 2021;16(4):e0249300. DOI:10.1371/journal.pone.0249300.; Kobayashi T., Kitaichi M., Tachibana K., Kishimoto Y., Inoue Y., Kagawa T. et al. A Cryptogenic Case of Fulminant Fibrosing Organizing Pneumonia. Intern. Med. 2017;56(10):1185–1191. DOI:10.2169/internalmedicine.56.7371.; Kim M., Cha S.I., Seo H., Shin K.M., Lim J.K., Kim H. et al. Predictors of Relapse in Patients with Organizing Pneumonia. Tuberc. Respir. Dis. (Seoul). 2015;78(3):190–195. DOI:10.4046/trd.2015.78.3.190.; Ailing L., Ning X., Tao Q., Aijun L. Successful treatment of suspected organizing pneumonia in a patient without typical imaging and pathological characteristic: A case report. Respir. Med. Case Rep. 2017;22:246–250. DOI:10.1016/j.rmcr.2017.09.007.; Barroso E., Hernandez L., Gil J., Garcia R., Aranda I., Romero S. Idiopathic organizing pneumonia: a relapsing disease. 19 years of experience in a hospital setting. Respiration. 2007;74(6):624–631. DOI:10.1159/000103240.; American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002;165(2):277–304. DOI:10.1164/ajrccm.165.2.ats01.; Ding Q.L., Lv D., Wang B.J., Zhang Q.L., Yu Y.M., Sun S.F. et al. Macrolide therapy in cryptogenic organizing pneumonia: A case report and literature review. Exp. Ther. Med. 2015;9(3):829–834. DOI:10.3892/etm.2015.2183.; Radzikowska E., Wiatr E., Langfort R., Bestry I., Skoczylas A., Szczepulska-Wójcik E. et al. Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study. PLoS One. 2017;12(9):e0184739. DOI:10.1371/journal.pone.0184739.; Cano E.J., Fonseca Fuentes X., Corsini Campioli C., O ҆Horo J.C., Abu Saleh O., Odeyemi Y. et al. Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis. Chest. 2021;159(3):1019–1040. DOI:10.1016/j.chest.2020.10.054.; Epler G.R. Bronchiolitis obliterans organizing pneumonia, 25 years: a variety of causes, but what are the treatment options? Expert. Rev. Respir. Med. 2011;5(3):353–361. DOI:10.1586/ers.11.19.; Lee J., Cha S.I., Park T.I., Park J.Y., Jung T.H., Kim C.H. Adjunctive effects of cyclosporine and macrolide in rapidly progressive cryptogenic organizing pneumonia with no prompt response to steroid. Intern. Med. 2011;50(5):475–479. DOI:10.2169/internalmedicine.50.4237.; Koinuma D., Miki M., Ebina M., Tahara M., Hagiwara K., Kondo T. et al. Successful treatment of a case with rapidly progressive Bronchiolitis obliterans organizing pneumonia (BOOP) using cyclosporin A and corticosteroid. Intern. Med. 2002;41(1):26–29. DOI:10.2169/internalmedicine.41.26.; Kory P., Kanne J.P. SARS-CoV-2 organising pneumonia: “Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?” BMJ Open Respir. Res. 2020;7(1):e000724. DOI:10.1136/bmjresp-2020-000724.; Vadász I., Husain-Syed F., Dorfmüller P., Roller F.C., Tello K., Hecker M. et al. Severe organising pneumonia following COVID-19. Thorax. 2021;76(2):201–204. DOI:10.1136/thoraxjnl-2020-216088.; Kanne J.P., Little B.P., Chung J.H., Elicker B.M., Ketai L.H. Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel. Radiology. 2020;296(2):E113–E114. DOI:10.1148/radiol.2020200527.; Fu F., Lou J., Xi D., Bai Y., Ma G., Zhao B. et al. Chest computed tomography findings of coronavirus disease 2019 (COVID-19) pneumonia. Eur. Radiol. 2020;30(10):5489–5498. DOI:10.1007/s00330-020-06920-8.; Rocha A.S., Meireles M., Vilaça H., Guimarães T.C., Martins M.D., Santos L.R. et al. Outcomes of Covid-19 organizing pneumonia in critically ill patients. J. Infect. 2021;83(4):496–522. DOI:10.1016/j.jinf.2021.06.025.; Antonio G.E., Wong K.T., Hui D.S., Wu A., Lee N., Yuen E.H. et al. Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology. 2003;228(3):810–815. DOI:10.1148/radiol.2283030726.; Cheung O.Y., Chan J.W., Ng C.K., Koo C.K. The spectrum of pathological changes in severe acute respiratory syndrome (SARS). Histopathology. 2004;45(2):119–124. DOI:10.1111/j.1365-2559.2004.01926.x.; Kim I., Lee J.E., Kim K.H., Lee S., Lee K., Mok J.H. Successful treatment of suspected organizing pneumonia in a patient with Middle East respiratory syndrome coronavirus infection: a case report. J. Thorac. Dis. 2016;8(10):E1190–E1194. DOI:10.21037/jtd.2016.09.26.; Elsoukkary S.S., Mostyka M., Dillard A., Berman D.R., Ma L.X., Chadburn A. et al. Autopsy Findings in 32 Patients with COVID-19: A Single-Institution Experience. Pathobiology. 2021;88(1):56–68. DOI:10.1159/000511325.; Borczuk A.C. Pulmonary pathology of COVID-19: a review of autopsy studies. Curr. Opin. Pulm. Med. 2021;27(3):184–192. DOI:10.1097/MCP.0000000000000761.; Copin M.C., Parmentier E., Duburcq T., Poissy J., Mathieu D. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. Intensive Care Med. 2020;46(6):1124–1126. DOI:10.1007/s00134-020-06057-8.; Buja L.M., Wolf D.A., Zhao B., Akkanti B., McDonald M., Lelenwa L. et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc. Pathol. 2020;48:107233. DOI:10.1016/j.carpath.2020.107233.; Liu H., Li J., Chen M., Su J. Glucocorticoid treatment of suspected organizing pneumonia after H7N9 infection: A case report. Medicine (Baltimore). 2019;98(34):e16839. DOI:10.1097/MD.0000000000016839.; Roden A.C., Bois M.C., Johnson T.F., Aubry M.C., Alexander M.P., Hagen C.E. et al. The Spectrum of Histopathologic Findings in Lungs of Patients With Fatal Coronavirus Disease 2019 (COVID-19) Infection. Arch. Pathol. Lab. Med. 2021;145(1):11–21. DOI:10.5858/arpa.2020-0491-SA.; Barbeta E., Benegas M., Sánchez M., Motos A., Ferrer M., Ceccato A. et al. Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients With COVID-19- and NonCOVID-19-Induced Acute Respiratory Distress Syndrome. Arch. Bronconeumol. 2022;58(2):183–187. DOI:10.1016/j.arbres.2021.05.023.; Bae I.-G., Hong K.-W., Yang J.W., Moon K.l., Kim J.D., Ju S. et al. Persistent pneumonic consolidations due to secondary organizing pneumonia in a patient recovering from COVID19 pneumonia: A case report. Preprint (Version 1) available at Research Square; 2020. DOI:10.21203/rs.3.rs-37580/v1.; Dhooria S. Comparison of the efficacy and safety of two corticosteroid regimens in the treatment of diffuse lung disease after coronavirus disease 2019 (COVID-19) pneumonia. ClinicalTrials.gov; 2022. URL: https://clinicaltrials.gov/ct2/show/NCT04657484 (27.01.2023).; Goel N., Goyal N., Nagaraja R., Kumar R. Systemic corticosteroids for management of “long-COVID”: an evaluation after 3 months of treatment. Monaldi Arch. Chest. Dis. 2021;92(2). DOI:10.4081/monaldi.2021.1981.; Ayub I.I. Clarithromycin in Post Covid 19 parenchymal organizing pneumonia. Clinical Trials Registry-India; 2020. URL: https://covid-19.cochrane.org/studies/crs-16896926 (13.12.2022).; Tan H.X., Lim J.L., shih Khor I., Kew Y.Ch., Yik W.F., Chan Y.M. et al. P16-60: Post COVID-19 organizing pneumonia treated with mycophenolate mofetil. Respirology. 2021;26(S3):473–474. DOI:10.1111/resp.14150_969.; Sugino K., Ono H., Haraguchi S., Igarashi S., Hebisawa A., Tsuboi E. Post-coronavirus disease 2019 organizing pneumonia confirmed pathologically by video-assisted thoracoscopic surgery. Respirol. Case Rep. 2021;9(12):e0871. DOI:10.1002/rcr2.871.; https://www.sibjcem.ru/jour/article/view/1788

Availability: https://www.sibjcem.ru/jour/article/view/1788
https://doi.org/10.29001/2073-8552-2023-38-2-64-71

View record from BASE

6

Academic Journal

Pancreatic islets as a SARS-CoV-2 target ; Островки поджелудочной железы человека как одна из мишеней SARS-CoV-2

Authors: O. V. Vorobеva, О. В. Воробьева

Source: Creative surgery and oncology; Том 12, № 4 (2022); 350-355 ; Креативная хирургия и онкология; Том 12, № 4 (2022); 350-355 ; 2076-3093 ; 2307-0501

Subject Terms: вирусная интерстициальная пневмония, COVID-19, SARS-CoV-2, pancreatic necrosis, histology, risk factors, viral interstitial pneumonia, панкреонекроз, гистология, факторы риска

File Description: application/pdf

Relation: https://www.surgonco.ru/jour/article/view/743/528; Воробьева О.В., Ласточкин А.В. Клинико-морфологический случай сахарного диабета, осложненного инфарктом миокарда. Профилактическая медицина. 2020;23(3):104–7. DOI:10.17116/profmed202023031104; Воробьева О.В. Изменения в органах при инфицировании COVID-19 с развитием септикопиемии. Профилактическая медицина. 2021;24(10):89–93. DOI:10.17116/profmed20212410189; Dambrauskas Z., Gulbinas A., Pundzius J. Meta-analysis of prophylactic parenteral antibiotic use in acute necrotizing pancreatitis. Medicina (Kaunas, Lithuania). 2007;43(4):291–300.; Juhász M.F., Ocskay K., Kiss S., Hegyi P., Párniczky A. Insufficient etiological workup of COVID-19-associated acute pancreatitis: A systematic review. World J Gastroenterol. 2020;26(40):6270–8. DOI:10.3748/wjg.v26.i40.6270; Bradley E.L. 3rd, Howard T.J., van Sonnenberg E., Fotoohi M. Intervention in necrotizing pancreatitis: an evidence-based review of surgical and percutaneous alternatives. J Gastrointest Surg. 2008;12(4):634–9. DOI:10.1007/s11605-007-0445-z; Fox C.J., Hammerman P.S., Thompson C.B. Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol. 2005;5(11):844–52. DOI:10.1038/nri1710; Gross V., Leser H.G., Heinisch A. Inflammatory mediators and cytokines — new aspects of the pathophysiology and assessment of severity of acute pancreatitis. Hepatogastroenterology. 1993;40(3):530–52. PMID: 7509768; Samanta J., Gupta R., Singh M.P., Patnaik I., Kumar A., Kochhar R. Coronavirus disease 2019 and the pancreas. Pancreatology. 2020;20(8):1567–75. DOI:10.1016/j.pan.2020.10.035; Wang F., Wang H., Fan J., Zhang Y., Wang H., Zhao Q. Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia. Gastroenterology. 2020;159(1):367–70. DOI:10.1053/j.gastro.2020.03.055; De-Madaria E., Siau K., Cardenas-Jaen K. Increased amylase and lipase in patients with COVID-19 pneumonia: don’t blame the pancreas just yet! Gastroenterology. 2020;S0016-5085(20)30561-8. DOI:10.1053/j.gastro.2020.04.044; Dioscoridi L. Pancreas and coronavirus disease-2019. Pancreas Open J. 2020;4(1):1–2. DOI:10.17140/POJ-4-111; Liu F., Long X., Zhang B., Zhang W., Chen X., Zhang Z. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol. 2020;18(9):2128–2130.e2. DOI:10.1016/j.cgh.2020.04.040; Abramczyk U., Nowaczyński M., Słomczyński A., Wojnicz P., Zatyka P., Kuzan A. Consequences of COVID-19 for the Pancreas. Int J Mol Sci. 2022;23(2):864. DOI:10.3390/ijms23020864.; Hadi A., Werge M., Kristiansen K.T., Pedersen U.G., Karstensen J.G., Novovic S., et al. Coronavirus disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members. Pancreatology. 2020;20(4):665–7. DOI:10.1016/j.pan.2020.04.021; Щикота А.М., Погонченкова И.В., Турова Е.А., Рассулов М.А., Филиппов М.С. Поражение желудочно-кишечного тракта, печени и поджелудочной железы при COVID-19. Доказательная гастроэнтерология. 2021;10(1):30–7. DOI:10.17116/dokgastro20211001130; https://www.surgonco.ru/jour/article/view/743

Availability: https://www.surgonco.ru/jour/article/view/743
https://doi.org/10.24060/2076-3093-2022-12-4-350-355

View record from BASE

7

Academic Journal

Worsening of a progressive interstitial lung disease in a patient with adult Still's disease after a novel coronavirus infection ; Ухудшение течения прогрессирующего интерстициального заболевания легких у пациентки с болезнью Стилла взрослых после перенесенной новой коронавирусной инфекции

Authors: Strutynskaya A.D., Karnaushkina M.A., Ovsyannikov D.Y., Filippov S.A., Tyurin I.E.

Contributors: 1

Source: Almanac of Clinical Medicine; Vol 50, No 2 (2022); 127-132 ; Альманах клинической медицины; Vol 50, No 2 (2022); 127-132 ; 2587-9294 ; 2072-0505

Subject Terms: adult Still's disease, nonspecific interstitial pneumonia, “honeycomb lung”, COVID-19, systemic connective tissue disorders, болезнь Стилла взрослых, неспецифическая интерстициальная пневмония, «сотовое легкое», системные заболевания соединительной ткани

File Description: application/pdf

Availability: https://almclinmed.ru/jour/article/view/1511
https://doi.org/10.18786/2072-0505-2022-50-013

View record from BASE

8

Academic Journal

A case of adenovirus infection complicated by diffuse alveolar haemorrage in a tourist from Sri Lanka

Authors: R. F. Sayfullin, M. A. Sayfullin, N. N. Zvereva, O. E. Ambrosi, V. R. Vengerov, S. K. Pylaeva

Source: Туберкулез и болезни лёгких, Vol 100, Iss 7, Pp 47-52 (2022)

Subject Terms: аденовирусная инфекция, аденовирус человека, диффузное альвеолярное кровотечение, интерстициальная пневмония, шри-ланка, Diseases of the respiratory system, RC705-779

Relation: https://www.tibl-journal.com/jour/article/view/1660; https://doaj.org/toc/2075-1230; https://doaj.org/toc/2542-1506; https://doaj.org/article/f141d24e4cea45b5a62877009e44eaee

Availability: https://doi.org/10.21292/2075-1230-2022-100-7-47-52
https://doaj.org/article/f141d24e4cea45b5a62877009e44eaee

View record from BASE

9

Academic Journal

HIV INFECTION IN PRACTICE OF PEDIATRIC PULMONOLOGIST

Authors: D.Yu. Ovsyannikov, Е.V. Boytsova, A.A. Speranskaya, D.M. Moskvina, Yu.P. Dutova, L.E. Konovalova, A.M. Shabalov

Source: Pediatriya-Zhurnal im G.N. Speranskogo

Subject Terms: children, ВИЧ-инфекция, respiratory diseases, bronchiectasis, pneumocystis pneumonia, лимфоидная интерстициальная пневмония, дети, HIV infection, пневмоцистная пневмония, бронхоэктазы, респираторные заболевания, lymphoid interstitial pneumonia, 3. Good health

Access URL: https://openrepository.ru/article?id=246423

View record at OpenAIRE

10

Academic Journal

Новая коронавирусная инфекция (COVID-19): танатологический анализ 220 аутопсий ; New coronavirus infection (COVID-19): thanatological analysis 220 autopsies

Authors: Eltsov, A. A., Makarova, V. V., Malov, Ya. S., Spirin, A. V., Ельцов, А. А., Макарова, В. В., Малов, Я. С., Спирин, А. В.

Source: Сборник статей

Subject Terms: CORONAVIRUS INFECTION, COVID-19, COVID-19 INTERSTITIAL PNEUMONIA, THANATOLOGICAL ANALYSIS, КОРОНАВИРУСНАЯ ИНФЕКЦИЯ, КОРОНАВИРУСНАЯ COVID-19 ИНТЕРСТИЦИАЛЬНАЯ ПНЕВМОНИЯ, ТАНАТОЛОГИЧЕСКИЙ АНАЛИЗ

File Description: application/pdf

Relation: Актуальные вопросы современной медицинской науки и здравоохранения: Материалы VI Международной научно-практической конференции молодых учёных и студентов, посвященной году науки и технологий, (Екатеринбург, 8-9 апреля 2021): в 3-х т.; http://elib.usma.ru/handle/usma/6833

Availability: http://elib.usma.ru/handle/usma/6833

View record from BASE

11

Academic Journal

A clinical case of idiopathic pulmonary fibrosis against the background of comorbid pathology

Authors: A. V. Teteneva, V. V. Kalyuzhin, G. M. Chernyavskaya, I. D. Bespalova, G. E. Chernogoryuk, V. D. Zavadovskaya, T. V. Zhogina, E. A. Ustyuzhanina, E. V. Kuzin, I. A. Varfolomeeva, O. V. Sedlyar, E. A. Medikova, Yu. I. Koshchavtseva, K. V. Potapov, A. I. Karzilov, Ya. V. Porovsky, M. M. Solovev

Source: Бюллетень сибирской медицины, Vol 20, Iss 3, Pp 225-232 (2021)

Subject Terms: идиопатический легочный фиброз, обычная интерстициальная пневмония, нинтеданиб, антифиброзная терапия, лечение, Medicine

Relation: https://bulletin.ssmu.ru/jour/article/view/4501; https://doaj.org/toc/1682-0363; https://doaj.org/toc/1819-3684; https://doaj.org/article/1b2e1509728441eb99a98eb523108e11

Availability: https://doi.org/10.20538/1682-0363-2021-3-225-232
https://doaj.org/article/1b2e1509728441eb99a98eb523108e11

View record from BASE

12

Academic Journal

Multidisciplinary approach to the diagnosis of nonspecific interstitial pneumonia (a case report) ; Мультидисциплинарный подход к диагностике неспецифической интерстициальной пневмонии (клиническое наблюдение)

Authors: S. I. Ovcharenko, E. A. Son, V. A. Osadchaya, V. A. Kapustina, С. И. Овчаренко, Е. А. Сон, В. А. Осадчая, В. А. Капустина

Source: PULMONOLOGIYA; Том 29, № 1 (2019); 106-111 ; Пульмонология; Том 29, № 1 (2019); 106-111 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2019-29-1

Subject Terms: мультиспиральная компьютерная томография, nonspecific interstitial pneumonia, multidisciplinary approach, multi-slice computed tomography, неспецифическая интерстициальная пневмония, идиопатическая неспецифическая интерстициальная пневмония, мультидисциплинарный подход

File Description: application/pdf

Relation: https://journal.pulmonology.ru/pulm/article/view/1114/899; Flaherty K.R., King T.E. Jr, Raghu G. et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am. J. Respir. Crit. Care Med. 2004; 170 (8): 904–910. DOI:10.1164/rccm.200402-147OC.; Travis W.D., Costabel U., Hansell D.M. et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013; 188 (6): 733–748. DOI:10.1164/rccm.201308-1483ST.; Travis W.D., Hunninghake G., King T.E. Jr. et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am. J. Respir. Crit. Care Med. 2008; 177 (12): 1338–1347. DOI:10.1164/rccm.200611-1685OC.; Cordier J.-F. Cryptogenic organising pneumonia. Eur. Resp. J. 2006; 28 (2): 422–446; DOI:10.1183/09031936.06.00013505.; Desai S.R., Veeraraghavan S., Hansell D.M. et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004; 232 (2): 560–567. DOI:10.1148/radiol.2322031223.; Nishiyama O., Kondoh Y., Taniguchi H. et al. Serial high resolution CT findings in nonspecific interstitial pneumonia/fibrosis. J. Comput. Assist. Tomog. 2000; 24 (1): 41–46. DOI:10.1097/00004728-200001000-00008.; Johkoh T., Müller N.L., Colby T.V. et al. Nonspecific interstitial pneumonia: Correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology. 2002; 225 (1): 199–204. DOI:10.1148/radiol.2251011555.; Park J.S., Lee K.S., Kim J.S. et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology. 1995; 195 (3): 645–648. DOI:10.1148/radiology.195.3.7753988.; Do K.H., Lee J.S., Colby T.V. et al. Nonspecific interstitial pneumonia versus usual interstitial pneumonia: differences in the density histogram of high-resolution CT. J. Comput. Assist. Tomogr. 2005; 29 (4): 544–548. DOI:10.1097/01.rct.0000164255.43859.96.; Hartman T.E., Swensen S.J., Hansell D.M. et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology. 2000; 217 (3): 701–705. DOI:10.1148/radiology.217.3.r00nv31701.; Чучалин А.Г., ред. Респираторная медицина: руководство в 3 т. 2-е изд., перераб. и доп. М.: Литтерра; 2017. Т. 3. Доступно на: http://www.rosmedlib.ru/book/ISBN9785423502621.html; Padley S.P., Adler B., Muller N.L. High-resolution computed tomography of the chest: current indications. J. Thorac. Imaging. 1993; 8 (3): 189–199.; Hansell D.M., Bankier A.A., MacMahon H. et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008; 246 (3): 697–722. DOI:10.1148/radiol.2462070712.; Nicholson A.G., Colby T.V., Wells A.U. Histopathological approach to patterns of interstitial pneumonia in patient with connective tissue disorders. Sarcoidosis Vasc. Diffuse Lung Dis. 2002; 19 (1): 10–17.; Fujita J., Yoshinouchi T., Ohtsuki Y. et al. Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis. Ann. Rheum. Dis. 2001; 60 (3): 281–283. DOI:10.1136/ard.60.3.281.; Bouros D., Wells A.U., Nicholson A.G. et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am. J. Respir. Crit. Care Med. 2002; 165 (12): 1581–1586. DOI:10.1164/rccm.2106012.; Tansey D., Wells A.U., Colby T.V. et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology. 2004; 44 (6): 585–596. DOI:10.1111/j.1365-2559.2004.01896.x.; Kim D.S., Yoo B., Lee J.S. et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma in nonspecific interstitial pneumonia. Sarcoidosis Vasc. Diffise Lung Dis. 2002; 19 (2): 121–127.; Flieder D.B., Travis W.D. Pathologic characteristics of drug-induced lung disease. Clin. Chest Med. 2004; 25 (1): 37–45. DOI:10.1016/s0272-5231(03)00138-2.; Rossi S.E., Erasmus J.J., McAdams H.P. et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. RadioGraphics. 2000; 20 (5): 1245–1259. DOI:10.1148/radiographics.20.5.g00se081245.; Pesenti S., Lauque D., Daste G. et al. Diffuse infiltrative lung disease associated with flecainide: report of two cases. Respiration. 2002; 69 (2): 182–185. DOI:10.1159/000056325.; Schwaiblmair M., Behr W., Haeckel T. et al. Drug induced interstitial lung disease. Open Respir. Med. J. 2012; 6: 63–74. DOI:10.2174/1874306401206010063.; https://journal.pulmonology.ru/pulm/article/view/1114

Availability: https://journal.pulmonology.ru/pulm/article/view/1114
https://doi.org/10.18093/0869-0189-2019-29-1-106-111

View record from BASE

13

Academic Journal

HIV-infection in practice of pediatric pulmonologist ; ВИЧ-инфекция в практике детского пульмонолога

Authors: Boytsova E.V., Ovsyannikov D.Yu., Moskvina D.M., Speranskaya A.A., Konovalova L.E., Dutova Yu.P., Shabalov A.M.

Source: Pediatriya - Zhurnal im G.N. Speranskogo

Subject Terms: HIV infection, respiratory diseases, pneumocystis pneumonia, bronchiectasis, lymphoid interstitial pneumonia, children, ВИЧ-инфекция, респираторные заболевания, пневмоцистная пневмония, бронхоэктазы, лимфоидная интерстициальная пневмония, дети

Relation: https://doi.org/10.24110/0031-403X-2018-97-2-55-60; https://openrepository.ru/article?id=246423

Availability: https://openrepository.ru/article?id=246423

View record from BASE

14

Academic Journal

Influence of AGT, TGFB1, ESR1, and VDR gene variants on development and course of idiopathic interstitial pneumonias and pulmonary sarcoidosis ; Влияние вариантов генов AGT, TGFB1, ESR1 и VDR на развитие и течение идиопатических интерстициальных пневмоний и саркоидоза органов дыхания

Authors: Anna S. Ulitina, Lubov’ N. Novikova, Yuliya M. Il'kovich, Olga P. Baranova, Tat'yana V. Makarova, Evgeniya V. Volkova, Sofiya N. Pchelina, Mikhail M. Il'kovich, Mikhail V. Dubina, А. С. Улитина, Л. Н. Новикова, Ю. М. Илькович, О. П. Баранова, Т. В. Макарова, Е. В. Волкова, С. Н. Пчелина, М. М. Илькович, М. В. Дубина

Source: PULMONOLOGIYA; Том 27, № 3 (2017); 346-356 ; Пульмонология; Том 27, № 3 (2017); 346-356 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2017-27-3

Subject Terms: однонуклеотидный полиморфизм, idiopathic interstitial pneumonias, sarcoidosis, genes, single nucleotide polymorphism, идиопатическая интерстициальная пневмония, саркоидоз, гены

File Description: application/pdf

Relation: https://journal.pulmonology.ru/pulm/article/view/876/741; Илькович М.М., ред. Интерстициальные и орфанные заболевания легких. М.: ГЭОТАР-Медиа; 2016.; Kreuter M., Herth F.J., Wacker M. et al. Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry –The EXCITING-ILD Registry. Biomed. Res. Int. 2015; 2015: 123876. DOI:10.1155/2015/123876.; Bajwa A., Osmanzada D., Osmanzada S. et al. Epidemiology of uveitis in the mid-Atlantic United States. Clin. Ophthalmol. 2015; (9): 889–901. DOI:10.2147/OPTH.S80972.; Mirsaeidi M., Machado R.F., Schraufnagel D. et al. Racial difference in sarcoidosis mortality in the United States. Chest. 2015; 147 (2): 438–449. DOI:10.1378/chest.14-1120.; Илькович М.М., Новикова Л.Н., Сперанская А.А. Идиопатический фиброзирующий альвеолит: современные представления. Consilium Medicum. 2009; (11): 24–29.; Чучалин А.Г., Визель А.А, Илькович М.М. и др. Диагностика и лечение саркоидоза: резюме федеральных согласительных клинических рекомендаций. Часть I. Классификация, этиопатогенез, клиника. Вестник современной клинической медицины. 2014; 7 (4): 62–70.; Inoue I., Nakajima T., Williams C.S. et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J. Clin. Invest. 1997; 99 (7): 1786–1797. DOI:10.1172/JCI119343.; Shu X.O., Gao Y.T., Cai Q. et al. Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res. 2004; 64 (3): 836–839.; van Meurs J.B., Schuit S.C., Weel A.E. et al. Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum. Mol. Genet. 2003; 12 (14): 1745–1754.; Horst-Sikorska W., Kalak R., Wawrzyniak A. et al. Association analysis of the polymorphisms of the VDR gene with bone mineral density and the occurrence of fractures. J. Bone Miner. Metab. 2007; 25 (5): 310–319. DOI:10.1007/s00774-007-0769-5.; Hofmann S., Fischer A., Nothnagel M. et al. Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosis. Eur. Respir. J. 2013; 41 (4): 888–900. DOI:10.1183/09031936.00033812.; Fingerlin T.E., Zhang W., Yang I.V. et al. Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia. BMC Genet. 2016; 17 (1): 74. DOI:10.1186/s12863-016-0377-2.; Fischer A., Grunewald J., Spagnolo P. et al. Genetics of sarcoidosis. Semin. Respir. Crit. Care Med. 2014; 35 (3): 296–306. DOI:10.1055/s-0034-1376860.; Zhou W., Wang Y. Candidate genes of idiopathic pulmonary fibrosis: current evidence and research. Appl. Clin. Genet. 2016; (9): 5–13. DOI:10.2147/TACG.S61999.; Molina-Molina M., Xaubet A., Li X. et al. Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression. Eur. Respir. J. 2008; 32 (4): 1004–1008. DOI:10.1183/09031936.00015808.; Arja C., Ravuri R.R., Pulamaghatta V.N. et al. Genetic determinants of chronic obstructive pulmonary disease in South Indian male smokers. PLoS One. 2014; 9 (2): e89957. DOI:10.1371/journal.pone.0089957.; Yang Y.C., Zhang N., Van Crombruggen K. et al. Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling. Allergy. 2012; 67 (10): 1193–1202. DOI:10.1111/j.1398-9995.2012.02880.x.; Shah R., Hurley C.K., Posch P.E. A molecular mechanism for the differential regulation of TGF-beta1 expression due to the common SNP -509C-T (c. -1347C > T). Hum. Genet. 2006; 120 (4): 461–469. DOI:10.1007/s00439-006-0194-1.; Jakimiuk A., Nowicka M., Bogusiewicz M. et al. Prevalence of estrogen receptor alpha PvuII and XbaI polymorphism in population of Polish postmenopausal women. Folia. Histochem. Cytobiol. 2007; 45 (4): 331–338.; Koppelman G.H., Sayers I. Evidence of a genetic contribution to lung function decline in asthma. J. Allergy Clin. Immunol. 2011; 128 (3): 479–484. DOI:10.1016/j.jaci.2011.05.036.; Uhal B.D., Kim J.K., Li X., Molina-Molina M. Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages. Curr. Pharm. Des. 2007; 13 (12): 1247–1256.; Daing A., Singh S.V., Saimbi C.S. et al. Single nucleotide polymorphisms at interleukin (IL)-1 b + 3954 and vitamin D receptor (VDR) TaqI in chronic periodontitis patients: A pilot study in North Indian population. J. Int. Clin. Dent. Res. Organ. 2015; 7: 18–23. DOI:10.4103/2231-0754.153490.; Perna L., Butterbach K., Haug U. et al. Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis. Cancer Epidemiol. Biomarkers Prev. 2013; 22 (3): 437–442. DOI:10.1158/1055-9965.EPI-12-0970-T.; Barna B.P., Culver D.A., Kanchwala A. et al. Alveolar macrophage cathelicidin deficiency in severe sarcoidosis. J. Innate Immun. 2012; 4 (5–6): 569–578. DOI:10.1159/000339149.; Hewison M. Vitamin D and the intracrinology of innate immunity. Mol. Cell Endocrinol. 2010; 321 (2): 103–111. DOI:10.1016/j.mce.2010.02.013.; Rivera N.V., Ronninger M., Shchetynsky K. et al. High-density genetic mapping identifies new susceptibility variants in sarcoidosis phenotypes and shows genomic-driven phenotypic differences. Am. J. Respir. Crit. Care Med. 2016; 193 (9): 1008–1022. DOI:10.1164/rccm.201507-1372OC.; https://journal.pulmonology.ru/pulm/article/view/876

Availability: https://journal.pulmonology.ru/pulm/article/view/876
https://doi.org/10.18093/0869-0189-2017-27-3-346-356

View record from BASE

15

Academic Journal

ЧАСТОТА И ОСОБЕННОСТИ «СИСТЕМНЫХ» ПРОЯВЛЕНИЙ У ПАЦИЕНТОВ С ИДИОПАТИЧЕСКИМИ ИНТЕРСТИЦИАЛЬНЫМИ ПНЕВМОНИЯМИ В УСЛОВИЯХ ПУЛЬМОНОЛОГИЧЕСКОГО ОТДЕЛЕНИЯ

Authors: ПЕТРОВА ДИНА ВЛАДИМИРОВНА, ШОЙХЕТ ЯКОВ НАХМАНОВИЧ, КОРНИЛОВА ТАТЬЯНА АЛЕКСАНДРОВНА, ЦЕЙМАХ ИРИНА ЯКОВЛЕВНА, КРАМАРЬ ИРИНА ПЕТРОВНА, БЕЛЯКОВА ИННА ИВАНОВНА, СОСНОВА ОКСАНА ЛЕОНИДОВНА

Subject Terms: ОБЫЧНАЯ ИНТЕРСТИЦИАЛЬНАЯ ПНЕВМОНИЯ, НЕСПЕЦИФИЧЕСКАЯ ИНТЕРСТИЦИАЛЬНАЯ ПНЕВМОНИЯ, КРИПТОГЕННАЯ ОРГАНИЗУЮЩАЯСЯ ПНЕВМОНИЯ, КЛИНИЧЕСКИЕ ПРОЯВЛЕНИЯ, "СИСТЕМНЫЕ" ПРОЯВЛЕНИЯ, "SYSTEMIC" MANIFESTATIONS

File Description: text/html

Availability: http://cyberleninka.ru/article/n/chastota-i-osobennosti-sistemnyh-proyavleniy-u-patsientov-s-idiopaticheskimi-interstitsialnymi-pnevmoniyami-v-usloviyah
http://cyberleninka.ru/article_covers/15955518.png

View record from BASE

16

Academic Journal

ВОЗМОЖНОСТИ МУЛЬТИДИСЦИПЛИНАРНОЙ ДИСКУССИИ В ДИАГНОСТИКЕ ИДИОПАТИЧЕСКОГО ЛЕГОЧНОГО ФИБРОЗА: АЛЬЯНС КЛИНИЦИСТ-РЕНТГЕНОЛОГ-ПАТОЛОГ

Authors: ПЕТРОВ Д.В., ТЮРИН И.Е., ЧЕРНЯЕВ А.Л., ГАУС О.В.

Subject Terms: ИДИОПАТИЧЕСКИЙ ЛЕГОЧНЫЙ ФИБРОЗ,ОБЫЧНАЯ ИНТЕРСТИЦИАЛЬНАЯ ПНЕВМОНИЯ,КЛИНИЧЕСКИЙ СЛУЧАЙ,АНТИФИБРОТИЧЕСКИЕ ПРЕПАРАТЫ,НИНТЕДАНИБ,IDIOPATHIC PULMONARY FIBROSIS,USUAL INTERSTITIAL PNEUMONIA,CLINICAL CASE,ANTIFIBROTIC DRUGS,NINTEDANIB

File Description: text/html

Availability: http://cyberleninka.ru/article/n/vozmozhnosti-multidistsiplinarnoy-diskussii-v-diagnostike-idiopaticheskogo-legochnogo-fibroza-alyans-klinitsist-rentgenolog-patolog
http://cyberleninka.ru/article_covers/16993067.png

View record from BASE

17

Academic Journal

Novel classification of idiopathic interstitial pneumonias: statement of American Thoracic Society / European Respiratory Society ; Новая классификация идиопатических интерстициальных пневмоний: совместный документ Американского торакального и Европейского респираторного обществ

Authors: статья Редакционная

Source: PULMONOLOGIYA; № 5 (2013); 9-24 ; Пульмонология; № 5 (2013); 9-24 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2013-0-5

Subject Terms: острая интерстициальная, usual interstitial pneumonia, nonspecific interstitial pneumonia, respiratory bronchiolitis, desquamative interstitial pneumonia, cryptogenic organizing pneumonia, acute interstitial pneumonia, lymphoid interstitial pneu, обычная интерстициальная пневмония, неспецифическая интерстициальная пневмония, респираторный бронхиолит, десквамативная интерстициальная пневмония, криптогенная организующаяся пневмония

File Description: application/pdf

Relation: https://journal.pulmonology.ru/pulm/article/view/274/273; American Thoracic Society, European Respiratory Society. American Thoracic Society / European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2002; 165: 277–304.; Travis W.D., Hunninghake G., King T.E. et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am. J. Respir. Crit. Care Med. 2008; 177: 1338–1347.; Aziz Z.A., Wells A.U., Hansell D.M. et al. HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax 2004; 59: 506–511.; Flaherty K.R., King T.E. Jr, Raghu G. et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am. J. Respir. Crit. Care Med. 2004; 170: 904–910.; Nicholson A.G., Addis B.J., Bharucha H. et al. Interobserver variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59: 500–505.; Thomeer M., Demedts M., Behr J. et al. Idiopathic Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur. Respir. J. 2008; 31: 585–591.; Flaherty K.R., Andrei A.&C., King T.E. et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am. J. Respir. Crit. Care Med. 2007; 175: 1054–1060.; Raghu G., Collard H.R., Egan J.J.et al. An official ATS / ERS / JRS / ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788–824.; Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin. Chest Med. 2004; 25: 531–547, vi.; Lynch D.A., Newell J.D., Logan P.M. et al. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? Am. J. Roentgenol. 1995; 165: 807–811.; Silva C.I., Churg A., Muller N.L. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. Am. J. Roentgenol. 2007; 188: 334–344.; Silva C.I.S., Muller N.L., Lynch D.A. et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246: 288–297.; Akashi T., Takemura T., Ando N. et al. Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. Am. J. Clin. Pathol. 2009; 131: 405–415.; Churg A., Muller N.L., Flint J., Wright J.L. Chronic hypersensitivity pneumonitis. Am. J. Surg. Pathol. 2006; 30: 201–208.; Churg A., Sin D.D., Everett D. et al. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am. J. Surg. Pathol. 2009; 33: 1765–1770.; Fenton M.E., Cockcroft D.W., Wright J.L., Churg A. Hypersensitivity pneumonitis as a cause of airway-centered interstitial fibrosis. Ann. Allergy Asthma Immunol. 2007; 99: 465–466.; Sahin H., Brown K.K., Curran&Everett D. et al. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology 2007; 244: 591–598.; Hanak V., Golbin J.M., Ryu J.H. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin. Proc. 2007; 82: 812–816.; Felicio C.H., Parra E.R., Capelozzi V.L. Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process. Lung 2007; 185: 39–46.; Park J.H., Kim D.S., Park I.N. et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am. J. Respir. Crit. Care Med. 2007; 175: 705–711.; Hwang J.&H., Misumi S., Sahin H. et al. Computed tomographic features of idiopathic fibrosing interstitial pneumonia: comparison with pulmonary fibrosis related to collagen vascular disease. J. Comput. Assist. Tomogr. 2009; 33: 410–415.; Song J.W., Do K.&H., Kim M.&Y. et al. Pathologic and radiologic differences between idiopathic and collagen vascular disease–related usual interstitial pneumonia. Chest 2009; 136: 23–30.; Corte T.J., Copley S.J., Desai S.R. et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur. Respir. J. 2012; 39: 661–668.; Suda T., Kono M., Nakamura Y. et al. Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir. Med. 2010; 104: 1527–1534.; Kinder B.W., Collard H.R., Koth L. et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am. J. Respir. Crit. Care Med. 2007; 176: 691–697.; Garcia&Sancho C., Buendia&Roldan I., Fernandez&Plata M.R. et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir. Med. 2011; 105: 1902–1907.; Hodgson U., Laitinen T., Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 2002; 57: 338–342.; Marshall R.P., Puddicombe A., Cookson W.O., Laurent G.J. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000; 55: 143–146.; Barlo N.P., van Moorsel C.H.M., Ruven H.J.T. et al. Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidos. Vasc. Diffuse Lung Dis. 2009; 26: 155–161.; Nogee L.M., Dunbar A.E. III, Wert S.E. et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 2001; 344: 573–579.; Kirwan M., Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochim. Biophys. Acta 2009; 1792: 371–379.; van Moorsel C.H., van Oosterhout M.F., Barlo N.P. et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am. J. Respir. Crit. Care Med. 2010; 182: 1419–1425.; Alder J.K., Chen J.J.L., Lancaster L. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 2008; 105: 13051–13056.; Cronkhite J.T., Xing C., Raghu G. et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 729–737.; Lawson W.E., Crossno P.F., Polosukhin V.V. et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am. J. Physiol. Lung Cell Mol. Physiol. 2008; 294: L1119–L1126.; Seibold M.A., Wise A.L., Speer M.C. et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 2011; 364: 1503–1512.; Zhang Y., Noth I., Garcia J.G., Kaminski N. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N. Engl. J. Med. 2011; 364: 1576–1577.; Lawson W.E., Loyd J.E., Degryse A.L. Genetics in pulmonary fibrosis – familial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Med. Sci. 2011; 341: 439–443.; Monaghan H., Wells A.U., Colby T.V. et al. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004; 125: 522–526.; Ryu J.H., Colby T.V., Hartman T.E., Vassallo R. Smokingrelated interstitial lung diseases: a concise review. Eur. Respir. J. 2001; 17: 122–132.; Aubry M.C., Wright J.L., Myers J.L. The pathology of smoking-related lung diseases. Clin. Chest Med. 2000; 21: 11–35, vii.; Vassallo R., Jensen E.A., Colby T.V. et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003; 124: 1199–1205.; Cottin V., Le Pavec J., Prevot G. et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur. Respir. J. 2010; 35: 105–111.; Cottin V., Cordier J.F. The syndrome of combined pulmonary fibrosis and emphysema. Chest 2009; 136: 1–2.; Cottin V., Nunes H., Brillet P.Y. et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005; 26: 586–593.; Mejia M., Carrillo G., Rojas&Serrano J. et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10–15.; Akira M., Inoue Y., Kitaichi M. et al. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings. Radiology 2009; 251: 271–279.; Flaherty K.R., Travis W.D., Colby T.V. et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2001; 164: 1722–1727.; Flaherty K.R., Thwaite E.L., Kazerooni E.A. et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58: 143–148.; Sverzellati N., Wells A.U., Tomassetti S. et al. Biopsyproved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses. Radiology 2010; 254: 957–964.; Sumikawa H., Johkoh T., Colby T.V. et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am. J. Respir. Crit. Care Med. 2008; 177: 433–439.; Silva C.I., Muller N.L., Hansell D.M. et al. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology 2008; 247: 251–259.; Lynch D.A., Godwin J.D., Safrin S. et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am. J. Respir. Crit. Care Med. 2005; 172: 488–493.; Kim E.Y., Lee K.S., Chung M.P. et al. Nonspecific interstitial pneumonia with fibrosis: serial highresolution CT findings with functional correlation. Am. J. Roentgenol. 1999; 173: 949–953.; Hartman T.E., Swensen S.J., Hansell D.M. et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000; 217: 701–705. [Published erratum appears in Radiology 218: 606.]; Park J.S., Lee K.S., Kim J.S. et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195: 645–648.; Cottin V., Donsbeck A.V., Revel D. et al. Nonspecific interstitial pneumonia: individualization of a clinicopathologic entity in a series of 12 patients. Am. J. Respir. Crit. Care Med.1998; 158: 1286–1293.; Nagai S., Kitaichi M., Itoh H. et al. Idiopathic nonspecific interstitial pneumonia / fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur. Respir. J. 1998; 12: 1010–1019.; Johkoh T., Muller N.L., Colby T.V. et al. Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 2002; 225: 199–204.; Johkoh T., Muller N.L., Cartier Y. et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999; 211: 555–560.; Nishiyama O., Kondoh Y., Taniguchi H. et al. Serial high resolution CT findings in nonspecific interstitial pneumonia / fibrosis. J. Comput. Assist. Tomogr. 2000; 24: 41–46.; MacDonald S.L., Rubens M.B., Hansell D.M. et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221: 600–605.; Akira M., Inoue Y., Arai T. et al. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax 2011; 66: 61–65.; Katzenstein A.L., Fiorelli R.F. Nonspecific interstitial pneumonia / fibrosis: histologic features and clinical significance. Am. J. Surg. Pathol. 1994; 18: 136–147.; Travis W.D., Matsui K., Moss J., Ferrans V.J. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am. J. Surg. Pathol. 2000; 24: 19–33.; Tsubamoto M., Muller N.L., Johkoh T. et al. Pathologic subgroups of nonspecific interstitial pneumonia: differential diagnosis from other idiopathic interstitial pneumonias on high-resolution computed tomography. J. Comput. Assist. Tomogr. 2005; 29: 793–800.; Park I.N., Jegal Y., Kim D.S. et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur. Respir. J. 2009; 33: 68–76.; Hidalgo A., Franquet T., Gimenez A. et al. Smoking-related interstitial lung diseases: radiologic–pathologic correlation. Eur. Radiol. 2006; 16: 2463–2470.; Craig P.J., Wells A.U., Doffman S. et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004; 45: 275–282.; Fraig M., Shreesha U., Savici D., Katzenstein A.L. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am. J. Surg. Pathol. 2002; 26: 647–653.; Vassallo R., Ryu J.H. Tobacco smoke-related diffuse lung diseases. Semin. Respir. Crit. Care Med. 2008; 29: 643–650.; Portnoy J., Veraldi K.L., Schwarz M.I. et al. Respiratory bronchiolitisinterstitial lung disease: long-term outcome. Chest 2007; 131: 664–671.; Doan M.L., Guillerman R.P., Dishop M.K. et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008; 63: 366–373.; Bullard J.E., Wert S.E., Whitsett J.A. et al. ABCA3 mutations associated with pediatric interstitial lung disease. Am. J. Respir. Crit. Care Med. 2005; 172: 1026–1031.; Kawabata Y., Hoshi E., Murai K. et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology 2008; 53: 707–714.; Katzenstein A.L., Mukhopadhyay S., Zanardi C., Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum. Pathol. 2010; 41: 316–325.; Snider G.L., Kleinerman J., Thurlbeck W.M., Bengali Z.H. The definition of emphysema: report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am. Rev. Respir. Dis.1985; 132: 182–185.; King T.E., Mortenson R. Cryptogenic organizing pneumonitis: the North American experience. Chest 1992; 102(1, Suppl): 8S–13S.; Lee J.W., Lee K.S., Lee H.Y. et al. Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients. Am. J. Roentgenol. 2010; 195: 916–922.; Sen T., Udwadia Z.F. Cryptogenic organizing pneumonia: clinical profile in a series of 34 admitted patients in a hospital in India. J. Assoc. Physicians India 2008; 56: 229–232.; Oymak F.S., Demirbas H.M., Mavili E. et al. Bronchiolitis obliterans organizing pneumonia: clinical and roentgenological features in 26 cases. Respiration 2005; 72: 254–262.; Lee J.S., Lynch D.A., Sharma S. et al. Organizing pneumonia: prognostic implication of high-resolution computed tomography features. J. Comput. Assist. Tomogr. 2003; 27: 260–265.; Lee K.S., Kullnig P., Hartman T.E., Muller N.L. Cryptogenic organizing pneumonia: CT findings in 43 patients. Am. J. Roentgenol. 1994; 162: 543–546.; Muller N.L., Staples C.A., Miller R.R. Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. Am. J. Roentgenol. 1990; 154: 983–987.; Ujita M., Renzoni E.A., Veeraraghavan S. et al. Organizing pneumonia: perilobular pattern at thin–section CT. Radiology 2004; 232: 757–761.; Kim S.J., Lee K.S., Ryu Y.H. et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. Am. J. Roentgenol. 2003; 180: 1251–1254.; Epler G.R., Colby T.V., McLoud T.C. et al. Bronchiolitis obliterans organizing pneumonia. N. Engl. J. Med. 1985; 312: 152–158.; Lohr R.H., Boland B.J., Douglas W.W. et al. Organizing pneumonia: features and prognosis of cryptogenic, secondary, and focal variants. Arch. Intern. Med. 1997; 157: 1323–1329.; Lazor R., Vandevenne A., Pelletier A. et al. Cryptogenic organizing pneumonia: characteristics of relapses in a series of 48 patients. Am. J. Respir. Crit. Care Med. 2000; 162: 571–577.; Fischer A., Swigris J.J., du Bois R.M. et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir. Med. 2009; 103: 1719–1724.; Bouros D., Nicholson A.C., Polychronopoulos V., du Bois R.M. Acute interstitial pneumonia. Eur. Respir. J. 2000; 15: 412–418.; Vourlekis J.S., Brown K.K., Cool C.D. et al. Acute interstitial pneumonitis: case series and review of the literature. Medicine (Baltimore) 2000; 79: 369–378.; Ichikado K., Suga M., Muller N.L. et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am. J. Respir. Crit. Care Med. 2002; 165: 1551–1556.; Primack S.L., Hartman T.E., Ikezoe J. et al. Acute interstitial pneumonia: radiographic and CT findings in nine patients. Radiology 1993; 188: 817–820.; Johkoh T., Muller N.L., Taniguchi H. et al. Acute interstitial pneumonia: thin-section CT findings in 36 patients. Radiology 1999; 211: 859–863.; Desai S.R., Wells A.U., Rubens M.B. et al. Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology 1999; 210: 29–35.; Ichikado K., Suga M., Muranaka H. et al. Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 cases. Radiology 2006; 238: 321–329.; Araya J., Kawabata Y., Jinho P. et al. Clinically occult subpleural fibrosis and acute interstitial pneumonia a precursor to idiopathic pulmonary fibrosis? Respirology 2008; 13: 408–412.; Rice A.J., Wells A.U., Bouros D. et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias: an autopsy study. Am. J. Clin. Pathol. 2003; 119: 709–714.; Song J.W., Hong S.B., Lim C.M. et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur. Respir. J. 2011; 37: 356–363.; Agarwal R., Jindal S.K. Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review. Eur. J. Intern. Med. 2008; 19: 227–235.; Silva C.I.S., Muller N.L., Fujimoto K. et al. Acute exacerbation of chronic interstitial pneumonia: high-resolution computed tomography and pathologic findings. J. Thorac. Imag. 2007; 22: 221–229.; Churg A., Muller N.L., Silva C.I.S., Wright J.L. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am. J. Surg. Pathol. 2007; 31: 277–284.; Suda T., Kaida Y., Nakamura Y. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir. Med. 2009; 103: 846–853.; Park I.N., Kim D.S., Shim T.S. et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007; 132: 214–220.; Miyazaki Y., Tateishi T., Akashi T. et al. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest 2008; 134: 1265–1270.; Collard H.R., Moore B.B., Flaherty K.R. et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007; 176: 636–643.; Akira M., Kozuka T., Yamamoto S., Sakatani M. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 372–378.; Akira M., Hamada H., Sakatani M. et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am. J. Roentgenol. 1997; 168: 79–83.; Fujimoto K., Taniguchi H., Johkoh T. et al. Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality. Eur. Radiol. 2012; 22: 83–92.; Cha S.I., Fessler M.B., Cool C.D. et al. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur. Respir. J. 2006; 28: 364–369.; Johkoh T., Muller N.L., Pickford H.A. et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999; 212: 567–572.; Reddy T.L., Tominaga M., Hansell D.M. et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur. Respir. J. 2012; 40: 377–385.; Becker C.D., Gil J., Padilla M.L. Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity? Mod. Pathol. 2008; 21: 784–787.; Frankel S.K., Cool C.D., Lynch D.A., Brown K.K. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004; 126: 2007–2013.; von der Thusen J.H., Hansell D.M., Tominaga M. et al. Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod. Pathol. 2011; 24: 1633–1639.; Amitani R., Niimi A., Kuze F. Idiopathic pulmonary upper lobe fibrosis (IPUF) [in Japanese]. Kokyu 1992; 11: 693–699.; Watanabe K., Nagata N., Kitasato Y. et al. Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir. Invest. 2012; 50: 88–97.; Beasley M.B., Franks T.J., Galvin J.R. et al. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch. Pathol. Lab. Med. 2002; 126: 1064–1070.; Balduin R., Giacometti C., Saccarola L. et al. Acute fibrinous and organizing pneumonia in a patient with collagen vascular disease "stigma". Sarcoidos. Vasc. Diffuse Lung Dis. 2007; 24: 78–80.; Hariri L.P., Mino&Kenudson M., Shea B. et al. Distinct histopathology of acute onset or abrupt exacerbation of hypersensitivity pneumonitis. Hum. Pathol. 2012; 43: 660–668.; Yokogawa N., Alcid D.V. Acute fibrinous and organizing pneumonia as a rare presentation of abacavir hypersensitivity reaction. AIDS 2007; 21: 2116–2117.; Churg A., Myers J., Suarez T. et al. Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am. J. Surg. Pathol. 2004; 28: 62–68.; Fukuoka J., Franks T.J., Colby T.V. et al. Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases. Am. J. Surg. Pathol. 2005; 29: 948–954.; Yousem S.A., Dacic S. Idiopathic bronchiolocentric interstitial pneumonia. Mod. Pathol. 2002; 15: 1148–1153.; Mark E.J., Ruangchira Urai R. Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation. Ann. Diagn. Pathol. 2008; 12: 171–180.; Ryerson C.J., Urbania T.H., Richeldi L. et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur. Respir. J. 2013; 42: 750–757.; Kinder B.W., Brown K.K., McCormack F.X. et al. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 2009; 135: 1557–1563.; Satoh H., Kurishima K., Ishikawa H., Ohtsuka M. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J. Intern. Med. 2006; 260: 429–434.; Prasse A., Probst C., Bargagli E. et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 179: 717–723.; Prasse A., Pechkovsky D.V., Toews G.B. et al. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthr. and Rheum. 2007; 56: 1685–1693.; Ishii H., Mukae H., Kadota J. et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 2003; 58: 52–57.; Ohnishi H., Yokoyama A., Kondo K. et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am. J. Respir. Crit. Care Med. 2002; 165: 378–381.; Casoni G.L., Ulivi P., Mercatali L. et al. Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis. Int. J. Biol. Markers 2010; 25: 229–235.; Pignatti P., Brunetti G., Moretto D. et al. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006; 173: 310–317.; Ishii H., Mukae H., Kadota J. et al. Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia. Respiration 2005; 72: 39–45.; Choi E.S., Pierce E.M., Jakubzick C. et al. Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. J. Clin. Pathol. 2006; 59: 28–39.; Choi E.S., Jakubzick C., Carpenter K.J. et al. Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2004; 170: 508–515.; Yang I.V., Burch L.H., Steele M.P. et al. Gene expression profiling of familial and sporadic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2007; 175: 45–54.; Lawson W.E., Grant S.W., Ambrosini V. et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004; 59: 977–980.; Kim K.K., Flaherty K.R., Long Q. et al. A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia. Mol. Med. 2003; 9: 52–56.; Markart P., Ruppert C., Wygrecka M. et al. Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias. Eur. Respir. J. 2007; 29: 134–137.; Zorzetto M., Ferrarotti I., Campo I. et al. NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. Sarcoidos. Vasc. Diffuse Lung Dis. 2005; 22: 180–185.; Hutyrova B., Pantelidis P., Drabek J. et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2002; 165: 148–151.; Renzoni E., Lympany P., Sestini P. et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthr. and Rheum. 2000; 43: 1633–1640.; Zorzetto M., Ferrarotti I., Trisolini R. et al. Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2003; 168: 330–334.; Hodgson U., Tukiainen P., Laitinen T. The polymorphism C5507G of complement receptor 1 does not explain idiopathic pulmonary fibrosis among the Finns. Respir. Med. 2005; 99: 265–267.; Kubistova Z., Mrazek F., Lympany P.A. et al. The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations. Tissue Antigens 2008; 72: 483–486.; Mushiroda T., Wattanapokayakit S., Takahashi A. et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J. Med. Genet. 2008; 45: 654–656.; Selman M., Lin H.&M., Montaño M. et al. Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum. Genet. 2003; 113: 542-550.; Falfán&Valencia R., Camarena A., Juárez A. et al. Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis. Hum. Genet. 2005; 118: 235–244.; Checa M., Ruiz V., Montaño M. et al. MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum. Genet. 2008; 124: 465–472.; Matsushima H., Takayanagi N., Sakamoto T. et al. Pathologic findings both before and after steroid therapy in a case of desquamative interstitial pneumonia [article in Japanese]. Nihon Kokyuki Gakkai Zasshi 2001; 39: 609–614.; Latsi P.I., du Bois R.M., Nicholson A.G. et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am. J. Respir. Crit. Care Med.2003; 168: 531–537.; Takahashi H., Fujishima T., Koba H. et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am. J. Respir. Crit. Care Med. 2000; 162: 1109–1114.; Greene K.E., King T.E., Kuroki Y. et al. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur. Respir. J. 2002; 19: 439–446.; Yokoyama A., Kondo K., Nakajima M. et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 2006; 11: 164–168.; Takahashi H., Shiratori M., Kanai A. et al. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology 2006; 11: S51–S54.; Daniil Z.D., Papageorgiou E., Koutsokera A. et al. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm. Pharmacol. Ther. 2008; 21: 26–31.; Rosas I.O., Richards T.J., Konishi K. et al. MMP1 and MMP7 as American Thoracic Society Documents 747 potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008; 5: e93.; Gilani S.R., Vuga L.J., Lindell K.O. et al. CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One 2010; 5: e8959.; Richards T.J., Kaminski N., Baribaud F. et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2012; 185: 67–76.; McKeown S., Richter A.G., O'Kane C. et al. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur. Respir. J. 2009; 33: 77–84.; Shinoda H., Tasaka S., Fujishima S. et al. Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 2009; 78: 285–292.; Richter A.G., McKeown S., Rathinam S. et al. Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis. Thorax 2009; 64: 156–161.; https://journal.pulmonology.ru/pulm/article/view/274; undefined

Availability: https://journal.pulmonology.ru/pulm/article/view/274

View record from BASE

18

Academic Journal